NBIX vs SLAB · P/E 45, rev $1.77B vs rev $441.7M
Neurocrine Biosciences Inc (NBIX) versus Silicon Laboratories Inc (SLAB) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Silicon Laboratories Inc (SLAB) is a semiconductors company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported SLAB revenue for 2026-07-04 was $441.7M. Net income was -$26.5M. SLAB currently screens at market cap $5.00B.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. SLAB currently screens at market cap $5.00B.
Not investment advice. Open the NBIX and SLAB stock pages for the full models.
Not investment advice.